NFKB2 and breast cancer: Finally, a prognostic signature based on nine ARGs (HSP90AA1, NFKB2, PLAU, PTK2, RECQL4, CLU, JAK2, MAP3K5, and S100B) were built based on 1046 patients with BC in the training set.